Innovations in Medical Devices: Medtronic Advanced Energy
-
Upload
unhinnovation-digiuseppe -
Category
Technology
-
view
2.478 -
download
2
description
Transcript of Innovations in Medical Devices: Medtronic Advanced Energy
University of New Hampshire
September 27, 2012
Suzanne Foster, VP & General Manager
2 | MDT Confidential
+
_____________________________
3 | MDT Confidential
New Building
• Leadership transition ‘07
• Moved to new facility ‘08
• Turned EBITDA positive ‘09
• Treated 500,000th patient in ‘10
• Acquired August ‘11
• Founded in 1999 with technology licensed from Medtronic
• First product sold ‘01 into solid organ resection
• Entered ortho market in ‘02
• Entered spine in ‘06
4 | MDT Confidential
Aquamantys Has Treated 1,000,000 Patients
0
50,000
100,000
150,000
200,000
250,00020
01
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
It took us six years to treat our 100,000th patient
1,000,000th Patient
It took us two years to treat our 250,000th patient
It took us 18 months to treat our 500,000th
patient
5 | MDT Confidential
Peak Surgical
• Technology developed at Stanford in 1998• PEAK Surgical, Inc. founded in May 2005• Peak licensed IP from Stanford
6 | MDT Confidential
Peak Surgical Rapid Growth
CommercialSuccess
20122006 2007 2009 2011
Series A & B $9M Lehman, Venrock
Mgmt team
Series C $23M Signet
Pre-clinical data
510(k) multiple surgical specialties
Mfg ramp-up
R&D PlasmaBlade & generator
Market research
Clinical study completed
US sales distribution
Strategic partnership Medtronic ENT
CE Mark OUS sales
2009 $3.5M US revenue
Focus on growth
Market penetration
50,000 cases
$8M US revenue
2008
08
2010
Commercial Release Continued
market penetration
100,000 cases/yr
$14M US revenue
MDT acquisition
Integration of PEAK into ST
PEAK Global Market Presence
PEAK Acquired
7 | MDT Confidential
Medtronic, Inc. • The Largest Medical
Device Company in the World
• 120 countries• 40,000 Employees
Worldwide• $14 Billion WW Revenue
8 | MDT Confidential
9 | MDT Confidential
The Aquamantys® System
Transcollation technology Family of single-use sealers
Epidural Vein Sealer (EVS)MBS
2.3 Bipolar
6.0 Bipolar
BSC 9.1
10 | MDT Confidential
Transcollation® Technology
Soft Tissue:
Broad Tissue Planes
Transcollation Target Tissues
Bone
=+
Solid Organs
• Delivers controlled thermal energy to target tissue
• Integrated saline and RF energy
• Proprietary algorithm controls power / saline flow relationship
Hemostatic SealHemostatic Seal
11 | MDT Confidential
Total Hip Arthroplasty
Total Knee Arthroplasty
Spine Surgery
Orthopaedic Trauma
Surgical Oncology
Applications of Transcollation® Technology
12 | MDT Confidential
Continuity of Care: Plays to our Strengths
Primary Care Pre-op Peri-op Post-op Discharge
Blood Management
Advanced Energy
Focus?
13 | MDT Confidential
4.0 3.0S Needle PULSAR II
The PlasmaBlade Family
14 | MDT Confidential
PlasmaBlade Solution…
Single Instrument Surgery…
− Precision cutting− Minimal bleeding − Less tissue damage
Less EnergyLess Heat
Reduced Collateral DamageReduced Inflammatory Cell Count
Improved Courseof Healing
PlasmaBlade
15 | MDT Confidential
PlasmaBlade TPS Insulation
TPS – Thermal Protection Shield
1% pulsed RF plasma discharge along– 12.5 microns wide exposed edge (~ width of human hair)
By reducing the amount of active electrode surface area, the system focuses and concentrates the energy to only the perimeter of the active electrode.
16 | MDT Confidential
PlasmaBlade TechnologyTissue Temperature Range: 40 – 170°C
The Difference…
Scalpel PlasmaBlade Electrosurgery
Electrosurgical PencilTissue Temperature Range: 250 – 370° C
17 | MDT ConfidentialFor Internal Use Only
Published March 16, 2011
From Dr.Viktor KrebsThe Cleveland Clinic
18 | MDT Confidential
Enforcement and Penalties
J&J - $81M & 5 Year CIA
AstraZeneca - $520M & 5 Year CIA
Pfizer - $2.3B & 5 Year CIA
GlaxoSmithKline - $3B
Medtronic - $40M & 5-Year CIA
Medtronic (Kyphon) - $75M & 5-Year CIA
Stryker Biotech – Former President and 3 Sales Managers indicted for
false statements and fraudulent marketing. Possible 20 years and $250K fine.
Synthes– Indictment and imprisonment of 4 senior executives
for off-label promotion– filed 510(k) for general indication with the intent to
rely on physician research and publication to target spine uses…BUT then promoted sine use w/out new 510k
19 | MDT Confidential
US Business Conduct Standards
• No gifts to customers, even for major life events• No logo items to customers, for example: pens,
notepads, mugs, and “reminder items”• Can provide occasional educational items and items
that benefit patients-must be less that $100 in value unless the item is a textbook or anatomical model
• No customer entertainment or recreation• No spouses or guests of customers (unless they are
qualified to attend in their own right)